Search clinical trials for: INC280 (capmatinib)
Total 906 results
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Novartis PharmaceuticalsAvailableNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Non-Small-Cell Lung Carcinoma
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalNovartisCompletedMalignant Non-small Cell Neoplasm of Lung Stage IVUnited States
-
Novartis PharmaceuticalsActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)China
-
National Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungItaly, Spain, Germany, Japan, Taiwan, Belgium, Netherlands, Singapore, Argentina, France, Israel, Sweden, Korea, Republic of, Lebanon, United Kingdom, United States, Austria, Mexico, Norway, Russian Federation
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Assistance Publique - Hôpitaux de ParisSuspendedGastric Adenocarcinoma | Oesophageal AdenocarcinomaFrance
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
Novartis PharmaceuticalsCompletedSolid TumorsGermany, United States, Netherlands, Spain, Canada, Hong Kong, Italy, Singapore, Australia, Israel, Korea, Republic of, Taiwan, France, Norway, Thailand
-
Collin BlakelyNovartisRecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung CancerUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Novartis PharmaceuticalsCompletedStudy of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung CancerCarcinoma, Non-Small-Cell LungUnited States, Belgium, Germany, France, Spain, Israel
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungJapan, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsCompletedMetastatic Non-Small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsWithdrawnNon-small Cell Lung Carcinoma (NSCLC)
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | MET Gene MutationKorea, Republic of
-
University of California, San FranciscoTerminatedALK Fusion Protein Expression | Stage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous Melanoma | ROS1 Fusion Positive | BRAF wt Allele | Invasive Skin Melanoma | MET Fusion Gene Positive | NRAS wt Allele | NTRK1 Fusion... and other conditionsUnited States
-
Timothy BurnsNovartisRecruitingNon-small Cell Lung CancerUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueNovartisCompletedNon Small Cell Lung Cancer | MET Alterations | METex14 MutationsFrance
-
Medline IndustriesEnrolling by invitationErythema | Skin Folds | Lesion Skin | MacerationUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Colorectal Cancer | Squamous Cell Carcinoma of Head and Neck (SCCHN)France, Belgium, Spain, Germany, Italy, Canada, United States
-
Bionomics LimitedCompletedSocial Anxiety DisorderUnited States
-
Novartis PharmaceuticalsRecruitingNon-Small Cell Lung CarcinomaIndia
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Bionomics LimitedCompletedPost-Traumatic Stress DisorderUnited States, United Kingdom
-
Bionomics LimitedCompleted
-
Bionomics LimitedCompleted
-
Intron Biotechnology, Inc.CompletedHealthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus AureusKorea, Republic of
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States